Last week, medical device maker Masimo announced new deals with Google and Qualcomm to bring its biosensing tech to Wear OS ...

Vivos Therapeutics (NASDAQ: VVOS) , a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related ...

LITTLETON, Colo., Sept. 19, 2024 (GLOBE NEWSWIRE) --. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization ...

Vivos Therapeutics shares surged 47.50% to close at $4.13, after hitting an intraday high of $5.95 and a low of $3.02. The ...

What a session it was for a certain Colorado-based %Healthcare company after it was announced that it received the US Food ...

Vivos Therapeutics is a pioneering medical device and technology company focused on addressing sleep-related breathing disorders (SRBDs), particularly obstructive sleep apnea (OSA). Their flagship ...

Vivos Therapeutics (VVOS) stock gains as company receives FDA clearance for its DNA appliance to treat obstructive sleep ...

Charting, Price Performance, News & Related Contracts.

TG Therapeutics, Inc. (NASDAQ:TGTX) stock is trading higher on Wednesday after the company announced it updated its data ...

Vivos Therapeutics (NASDAQ: VVOS), a leading medical-device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related ...

On Wednesday, the FDA granted 510(k) clearance to Vivos Therapeutics, Inc.’s (NASDAQ:VVOS) flagship oral medical device, ...

Vivos Therapeutics shares rose on Wednesday after the company said its oral medical device for pediatric sleep apnea and snoring received 510(k) clearance from the Food and Drug Administration. Shares ...